Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for ...

Gilead has agreed to acquire Tubulis, a private, clinical-stage biotechnology company focused on developing next-generation ...

Eli Lilly’s Foundayo (orforglipron), the only oral GLP-1 weight loss treatment that can be taken at any time of the day with no food or water restrictions, has been approved by ...

Released to coincide with World World Health Day on 7 April, the latest Health Futures report from VML Health suggests the next big wins in health won’t come from science alone, but from turning ...

When PharmaQuest returned at the World Evidence, Pricing and Access (EPA) Congress 2026, we examined whether the priorities ...

Novo Nordisk’s Awiqli (insulin icodec) has been approved by the US FDA as the first and only once-weekly, long-acting basal ...

ReproNovo has appointed Mark Altmeyer as Chairman of the Board of Directors. Bringing over 35 years of experience to the role ...

Sandoz has partnered with Samsung Bioepis to broaden patient access to high-quality biosimilar medicines worldwide. The ...

Novartis is to acquire Excellergy, a private biotech company developing next-generation anti-IgE therapies for IgE-driven ...

The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct ...

Current Chair, Dom Marchant, will be stepping down, but will continue to oversee the Creativity for Good initiative ...

Opdivo (nivolumab) has been approved for two new classical Hodgkin lymphoma (cHL) indications in the US and the EU. The US ...